JNJ-42165279
Product Specifications
UNSPSC Description
JNJ-42165279 is an orally active FAAH inhibitor, with IC50 values of 70 nM for hFAAH and 313 nM for rFAAH. JNJ-42165279 can be used in research related to the field of neuropathic pain[1][2].
Target Antigen
Autophagy; FAAH
Type
Reference compound
Related Pathways
Autophagy;Metabolic Enzyme/Protease;Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/JNJ-42165279.html
Purity
99.87
Solubility
DMSO : ≥ 100 mg/mL
Smiles
O=C(N1CCN(CC2=CC=C(OC(F)(F)O3)C3=C2)CC1)NC4=C(Cl)C=CN=C4
Molecular Weight
410.80
References & Citations
[1]Keith JM, et al. Preclinical Characterization of the FAAH Inhibitor JNJ-42165279. ACS Med Chem Lett. 2015 Nov 2;6(12):1204-8.|[2]van Heerden M, et al. Exacerbation of Background Nuclear Cataracts in Sprague-Dawley Rats in Embryo-Fetal Development Studies With JNJ-42165279, a Fatty Acid Amide Hydrolase Inhibitor. Toxicol Pathol. 2021 Aug;49(6):1193-1205.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-19636/JNJ-42165279-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-19636/JNJ-42165279-SDS-MedChemExpress.pdf
Clinical Information
Phase 2
CAS Number
1346528-50-4
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1328685-01 0.02 mg (E-Coli)
Recombinant Bartonella henselae tRNA modification GTPase MnmE (mnmE)
Ask
View Details 
MBS1328685-02 0.02 mg (Yeast)
Recombinant Bartonella henselae tRNA modification GTPase MnmE (mnmE)
Ask
View Details MBS1328685-03 0.1 mg (E-Coli)
Recombinant Bartonella henselae tRNA modification GTPase MnmE (mnmE)
Ask
View Details MBS1328685-04 0.1 mg (Yeast)
Recombinant Bartonella henselae tRNA modification GTPase MnmE (mnmE)
Ask
View Details